1
Participants
Start Date
November 27, 2023
Primary Completion Date
August 8, 2024
Study Completion Date
August 8, 2024
BMS-986315
Specified dose on specified days
Nivolumab
Specified dose on specified days
Pemetrexed
Specified dose on specified days
Cisplatin
Specified dose on specified days
Carboplatin
Specified dose on specified days
Paclitaxel
Specified dose on specified days
Local Institution - 0013, St Leonards
Local Institution - 0021, Tweed Heads
Local Institution - 0032, Joondalup
Local Institution - 0040, Orange City
Local Institution - 0044, Clermont
Local Institution - 0038, Glendale
Local Institution - 0049, Houston
Local Institution - 0058, Boise
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY